Published studies on TLR4 Asp299Gly polymorphism and CHD susceptibility have generally revealed conflicting data, partially because of the possible weak effect of the polymorphism and the relatively small sample size in individual studies. This evidence concerns the gene TLR4 and coronary artery disorder.